Zobrazeno 1 - 6
of 6
pro vyhledávání: '"M. D. DeFuria"'
Autor:
M D, DeFuria, Z, Horovitz
Publikováno v:
Journal of the National Cancer Institute. Monographs. (15)
Evidence of Taxol's safety and efficacy for treatment of refractory ovarian cancer convinced the National Cancer Institute (NCI) to seek a pharmaceutical partner and approval. After an open competition, NCI entered a Cooperative Research and Developm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f5a8eed8398681e475ca92fb0427d48e
https://pubmed.ncbi.nlm.nih.gov/7912526
https://pubmed.ncbi.nlm.nih.gov/7912526
Publikováno v:
Antimicrobial Agents and Chemotherapy. 5:143-152
One hundred fifty-two bacterial strains that possess resistance to kanamycin A, gentamicin, or tobramycin, or to more than one of these antibiotics, were collected from various sources in Canada, Europe, Japan, and the United States. This collection
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef0aef2e4314e20f80ae353a099913b8
https://doi.org/10.1128/aac.5.2.143
https://doi.org/10.1128/aac.5.2.143
Publikováno v:
Cancer research. 40(2)
The intravesical administration of mitomycin C to normal and N-[4-(5-nitro-2-furyl)-2-thiozolyl]formamide-induced bladder tumor-carrying mice at initial concentrations of 2 and 5 mg/ml for 2 hr resulted in marked morphological effects including cytop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::86e84e4703de1d74f4a58a8e8fbb0316
https://pubmed.ncbi.nlm.nih.gov/7356509
https://pubmed.ncbi.nlm.nih.gov/7356509
Publikováno v:
The Journal of infectious diseases.
A total of 319 clinical isolates known to be resistant to one or more aminoglycoside antibiotics were tested for their susceptibility to 10 aminoglycosides. The percentages of isolates found by an agar dilution method to be susceptible were: amikacin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa1becabe3c3bc747b2c6aa7226ea9ca
https://pubmed.ncbi.nlm.nih.gov/62814
https://pubmed.ncbi.nlm.nih.gov/62814
Publikováno v:
Cancer treatment reports. 63(5)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::14edf43d65c762efbd4bd255d03c300e
https://pubmed.ncbi.nlm.nih.gov/110446
https://pubmed.ncbi.nlm.nih.gov/110446
Autor:
M D, DeFuria, R B, Bracken, D E, Johnson, M S, Soloway, C E, Merrin, L R, Morgan, H C, Miller, S T, Crooke
Publikováno v:
Cancer treatment reports. 64(2-3)
Intravesical mitomycin C therapy was administered to 63 patients with noninvasive bladder carcinoma in a phase I-II study. Doses ranged from 20 to 60 mg once a week for 8 weeks. The overall response rate was 67% including a complete remission rate of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a11b7acb65c2d93d467de6882cf0eb74
https://pubmed.ncbi.nlm.nih.gov/7407754
https://pubmed.ncbi.nlm.nih.gov/7407754